Membranous nephropathy with proteinase 3-anca-associated vasculitis successfully treated with rituximab

11Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Membranous nephropathy (MN) with anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (ANCA-GN) is seen infrequently. Previous reports of patients with ANCA-GN with MN showed that the most frequent ANCA subtype was myeloperoxidase-ANCA. We herein present a 73-year-old woman with scleritis, hematuria, proteinuria, and positive serum proteinase 3 (PR3)-ANCA. She underwent a renal biopsy and was diagnosed with MN and ANCA-GN. Immunofluorescence staining for PR3 colocalized with IgG along the glomerular basement membrane were observed. Oral prednisolone and intravenous rituximab therapy immediately improved her symptoms and urinalysis abnormalities. PR3-ANCA may be involved in the pathogenesis of MN via the formation of immune complexes.

Cite

CITATION STYLE

APA

Yoshida, S., Hanai, S., Nakagomi, D., Kobayashi, K., Takahashi, K., & Furuya, F. (2021). Membranous nephropathy with proteinase 3-anca-associated vasculitis successfully treated with rituximab. Internal Medicine, 60(1), 145–150. https://doi.org/10.2169/internalmedicine.4752-20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free